What a difference a year makes. The start of the annual J.P. Morgan Healthcare investor conference in 2019 brought a double-header of giant deals. In 2020, there was almost nothing. That wasn’t good news for biotech stocks. The iShares Nasdaq Biotech ETF ended Monday down 1.1% and the SPDR S&P Biotech ETF fell 2%.